Assertio Therapeutics to be acquired by Zydus Worldwide

Assertio Therapeutics ( (ASRT) ) has shared an update.

On May 13, 2026, Assertio Holdings, Inc. agreed to be acquired by Zydus Worldwide DMCC, which will launch a cash tender offer on May 18, 2026, through a subsidiary to purchase all outstanding Assertio common shares at $23.50 per share, followed by a merger that will make Assertio a wholly owned subsidiary. The merger will trigger a Fundamental Change and a Make-Whole Fundamental Change under Assertio’s 6.50% Convertible Senior Notes due 2027, giving noteholders the right to require a cash repurchase at par plus accrued interest or to convert their notes at an increased conversion rate into the merger consideration, while Zydus has waived a requirement for Assertio to commence a separate note repurchase and consent solicitation offer.

The most recent analyst rating on (ASRT) stock is a Hold with a $23.50 price target. To see the full list of analyst forecasts on Assertio Therapeutics stock, see the ASRT Stock Forecast page.

Spark’s Take on ASRT Stock

According to Spark, TipRanks’ AI Analyst, ASRT is a Neutral.

The score is held back primarily by deteriorating fundamentals (shrinking revenue, losses, and negative TTM cash flow). Offsetting positives include the announced all-cash acquisition providing a near-term price anchor, constructive FY2026 guidance tied to Robodon-driven EBITDA expansion, and a strong price trend—though technicals are extremely overbought, increasing pullback risk.

To see Spark’s full report on ASRT stock, click here.

More about Assertio Therapeutics

Assertio Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing therapies, including convertible debt financing through its 6.50% Convertible Senior Notes due 2027. The company operates through a publicly traded common stock structure and utilizes note indentures that include restrictive covenants and conversion features impacting its capital structure and investor base.

Average Trading Volume: 261,154

Technical Sentiment Signal: Hold

Current Market Cap: $150.7M

See more insights into ASRT stock on TipRanks’ Stock Analysis page.